Login

DDMAC to Hold Webinar on 2011 Enforcement Actions

Aug. 3, 2011 — The FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) announced today that it would hold its second Enforcement Webinar on Thursday, Aug. 25, from 11 AM EST to 11:30 AM EST.

“This is a pilot program in which DDMAC will give our stakeholders a chance to directly communicate with the Agency on clarifications or questions about the Warning Letters and Untitled Letters issued by DDMAC in a given quarter,” the DDMAC announcement states. Viewers can begin submitting questions 30 minutes prior to Webinar start time. This particular Webinar will cover Warning Letters and Untitled Letters issued from May 2011 to August 2011.

DDMAC is holding “focused Webinars” that “will support DDMAC’s mission to protect the public health by assuring prescription drug information is truthful, balanced, and accurately communicated.”

Meeting details follow:

To join the meeting:
https://collaboration.fda.gov/ddmac2/

For Audio:
Conference Number(s): 301-796-2700
Participant Code: 232312

If you only take one supplement take this one! It supports your immune system from the inside! Your body will thank you. Viagra professional. Generic drugs are required to have the same active ingredient, strength, dosage form, and route of administration as the brand name product.

Categories

Recent Posts

Tags

ACA ad tax CDER chc CMS coalition for healthcare communication conflict of interest Congress COVID-19 data privacy data privacy legislation DDMAC drug prices in DTC ads drug pricing DTC DTC advertising DTC advertising FDA FDA Commissioner FDA Draft Guidance FDA enforcement FDA social media FTC gifts to physicians HHS Jim Potter John Kamp Jon Bigelow kamp Kate Rawson legislation litigation off-label off-label communication OPDP OPDP enforcement PhRMA regulation rx data Scott Gottlieb social media sunshine act Untitled Letter Warning Letter Wayne Pines